SUN-LB054 Cilengitide Reverts Thyroid Hormones Effects in Bexarotene Treatment of Breast Cancer Cells

Bexarotene (Bex) is an oral retinoid-X-receptor agonist that is effective for the treatment of early and advanced-stage in cutaneous T cell lymphoma. There are ongoing clinical trials to determine its role in both breast cancer treatment and prevention. Unfortunately, hypothyroidism is recognized as...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Endocr Soc
Главные авторы: Díaz Albuja, Johanna, Debernardi, María, Cayrol, Florencia, Rosemblit, Cinthia, Cremaschi, Graciela, Díaz Flaqué, María
Формат: Artigo
Язык:Inglês
Опубликовано: Endocrine Society 2019
Предметы:
Tumor Biology
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6553160/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-LB054
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы